Yasir Safak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yasir Safak has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Hüseyin Şehit Burhan
Department of Psychiatry, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
3 shared publications - Kadir Özdel
Department of Psychiatry, Etlik City Hospital, Ankara, Turkey
3 shared publications - Elif Aktan Mutlu
Department of Psychiatry, Ankara Etlik City Hospital, Ankara, Türkiye
2 shared publications - Elif Erdem
Department of Psychiatry, Ankara Etlik City Hospital, Ankara, Türkiye
2 shared publications Sibel Orsel
Saglik Bilimleri Univ Diskapi Yildirim Beyazit Eg, Psikiyatri Klin, Ankara, Turkey
2 shared publications- Ayse Gokcen Gundogmus
Department of Psychiatry, Ankara Etlik City Hospital, Ankara 06170, Turkey
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Springer Nature in BMC Psychiatry
Clinical and financial correlates of suicide attempts among patients with gambling disorder: a retrospective study
Background: Gambling disorder (GD) is strongly associated with suicidal behavior; however, the specific clinical and financial factors associated with gambling-related suicide attempts remain insufficiently understood. This study aimed to compare the sociodemographic, clinical, and financial characteristics of individuals with GD with and without gambling-related suicide attempts and to identify independent factors associated with these attempts. Methods: This retrospective, descriptive, and comparative study included 342 patients diagnosed with GD according to DSM-5 criteria at a specialized addiction outpatient clinic between September 2023 and December 2025. Sociodemographic, clinical, and financial data were obtained from medical records. Gambling severity was assessed using the South Oaks Gambling Screen (SOGS). Patients were classified according to the presence or absence of gambling-related suicide attempts identified through retrospective review of clinical records. Univariable and multivariable logistic regression analyses were performed to identify factors associated with gambling-related suicide attempts. Results: The prevalence of lifetime suicide attempts in the sample was 13.2%. Traditional sociodemographic variables commonly considered protective against suicide in the general population (e.g., marriage, parenthood, social support) were not significantly associated with suicide attempts in this sample. In univariable analyses, higher gambling severity, depression, Cluster B personality disorders, history of deliberate self-harm (DSH), and financial hardship were significantly associated with gambling-related suicide attempts. After multivariable adjustment, history of DSH (OR = 15.894, 95% CI: 3.270–77.253), presence of psychiatric comorbidity (OR = 14.549, 95% CI: 1.799–117.650), and a debt-to-monthly income ratio > 30 (OR = 8.806, 95% CI: 1.777–43.625) remained independently associated with gambling-related suicide attempts. Conclusions: Gambling-related suicide attempts appear to be more closely associated with disorder-specific clinical and financial characteristics than with traditional sociodemographic variables. A history of deliberate self-harm, psychiatric comorbidity, and severe relative financial burden (debt-to-income ratio > 30) emerged as independent correlates of gambling-related suicide attempts. These findings support comprehensive suicide risk assessment in gambling disorder that incorporates self-harm history, psychiatric comorbidity, and financial strain in addition to gambling severity. Clinical trial number: Not applicable.
- 18 September 2026
- Published by Springer Nature in BMC Psychiatry
Open AccessClinical and financial correlates of suicide attempts among patients with gambling disorder: a retrospective study
Background: Gambling disorder (GD) is strongly associated with suicidal behavior; however, the specific clinical and financial factors associated with gambling-related suicide attempts remain insufficiently understood. This study aimed to compare the sociodemographic, clinical, and financial characteristics of individuals with GD with and without gambling-related suicide attempts and to identify independent factors associated with these attempts. Methods: This retrospective, descriptive, and comparative study included 342 patients diagnosed with GD according to DSM-5 criteria at a specialized addiction outpatient clinic between September 2023 and December 2025. Sociodemographic, clinical, and financial data were obtained from medical records. Gambling severity was assessed using the South Oaks Gambling Screen (SOGS). Patients were classified according to the presence or absence of gambling-related suicide attempts identified through retrospective review of clinical records. Univariable and multivariable logistic regression analyses were performed to identify factors associated with gambling-related suicide attempts. Results: The prevalence of lifetime suicide attempts in the sample was 13.2%. Traditional sociodemographic variables commonly considered protective against suicide in the general population (e.g., marriage, parenthood, social support) were not significantly associated with suicide attempts in this sample. In univariable analyses, higher gambling severity, depression, Cluster B personality disorders, history of deliberate self-harm (DSH), and financial hardship were significantly associated with gambling-related suicide attempts. After multivariable adjustment, history of DSH (OR = 15.894, 95% CI: 3.270–77.253), presence of psychiatric comorbidity (OR = 14.549, 95% CI: 1.799–117.650), and a debt-to-monthly income ratio > 30 (OR = 8.806, 95% CI: 1.777–43.625) remained independently associated with gambling-related suicide attempts. Conclusions: Gambling-related suicide attempts appear to be more closely associated with disorder-specific clinical and financial characteristics than with traditional sociodemographic variables. A history of deliberate self-harm, psychiatric comorbidity, and severe relative financial burden (debt-to-income ratio > 30) emerged as independent correlates of gambling-related suicide attempts. These findings support comprehensive suicide risk assessment in gambling disorder that incorporates self-harm history, psychiatric comorbidity, and financial strain in addition to gambling severity. Clinical trial number: Not applicable.
- Open Access
- 15 April 2026
- Published by Current Approaches in Psychiatry in Psikiyatride Güncel Yaklaşımlar
- Vol. 18 (3) , 1076-1088
Metacognition and Metacognitive Therapy in Gambling Disorder
Gambling Disorder (GD) is associated with substantial financial, psychological, and interpersonal harms. Emerging evidence highlights metacognitive mechanisms as central to the onset and maintenance of addictive behaviors. This narrative review synthesizes theoretical and empirical work on metacognitions, the Self-Regulatory Executive Function (S-REF) model, and the Cognitive Attentional Syndrome (CAS) in GD, and evaluates the therapeutic promise of Metacognitive Therapy (MCT). Positive and negative metacognitive beliefs shape how individuals appraise and control internal experiences, fostering maladaptive cycles marked by desire thinking, rumination, attentional bias, and thought suppression. These processes impair monitoring, reduce attentional flexibility, and degrade decision-making, while emotion-regulation deficits across identification, selection, and implementation further perpetuate gambling. Within the S-REF/CAS framework, GD is conceptualized as a cyclical pattern sustained by rigid, repetitive processing of threat- and reward-related cognitions. MCT targets these processes directly via techniques such as detached mindfulness and the attention training technique, aiming to weaken repetitive negative thinking and restore cognitive control. Preliminary evidence including an eight-session pilot focused on gambling-specific distortions suggests acceptability and reductions in cognitive distortions, with broader support from trials in anxiety, depression, and substance use indicating superior or comparable outcomes to cognitive behavioral and acceptance-based approaches. We conclude that metacognitive dysfunctions constitute actionable treatment targets in GD and that MCT is a theoretically coherent, promising intervention.
- 15 April 2026
- Published by Current Approaches in Psychiatry in Psikiyatride Güncel Yaklaşımlar
- Vol. 18 (3) , 1076-1088
Open AccessMetacognition and Metacognitive Therapy in Gambling Disorder
Gambling Disorder (GD) is associated with substantial financial, psychological, and interpersonal harms. Emerging evidence highlights metacognitive mechanisms as central to the onset and maintenance of addictive behaviors. This narrative review synthesizes theoretical and empirical work on metacognitions, the Self-Regulatory Executive Function (S-REF) model, and the Cognitive Attentional Syndrome (CAS) in GD, and evaluates the therapeutic promise of Metacognitive Therapy (MCT). Positive and negative metacognitive beliefs shape how individuals appraise and control internal experiences, fostering maladaptive cycles marked by desire thinking, rumination, attentional bias, and thought suppression. These processes impair monitoring, reduce attentional flexibility, and degrade decision-making, while emotion-regulation deficits across identification, selection, and implementation further perpetuate gambling. Within the S-REF/CAS framework, GD is conceptualized as a cyclical pattern sustained by rigid, repetitive processing of threat- and reward-related cognitions. MCT targets these processes directly via techniques such as detached mindfulness and the attention training technique, aiming to weaken repetitive negative thinking and restore cognitive control. Preliminary evidence including an eight-session pilot focused on gambling-specific distortions suggests acceptability and reductions in cognitive distortions, with broader support from trials in anxiety, depression, and substance use indicating superior or comparable outcomes to cognitive behavioral and acceptance-based approaches. We conclude that metacognitive dysfunctions constitute actionable treatment targets in GD and that MCT is a theoretically coherent, promising intervention.
- Open Access
- 31 January 2025
- Published by Turkish Journal of Traumatic Stress in Turkish Journal of Traumatic Stress
- Vol. 1 (1) , 3-13
The Mediating Role of Dissociation in the Relationship Between Alexithymia and Symptom Severity in Patients with Post-traumatic Stress Disorder
Background: This study aimed to reveal the complex relationship between symptom severity, dissociation, and alexithymia in patients with post-traumatic stress disorder (PTSD). It also focuses on whether dissociative symptoms mediate the link between alexithymia and PTSD symptom severity. Methods: The study included 85 patients who were referred to a psychiatric clinic and diagnosed with PTSD according to the Diagnostic and Statistical Manual of Mental Disorders-5 diagnostic criteria. Participants were assessed using the sociodemographic data form, the Event Impact Scale-Revised (IES-R), the Dissociative Experiences Scale (DES), and the Toronto Alexithymia Scale (TAS-20). Results: The mean age of 85 PTSD patients included in the study was 31.90 years and 69.4% (n=59) were female. According to the TAS-20 scale of the participants; 62.4% (n=53) were alexithymic and 37.6% (n=32) were non-alexithymic. The two groups had no statistically significant difference in sociodemographic variables (p>0.05). A statistically significant difference was found between the two groups in DES (p=0.004) and TAS (p<0.001). A positive statistically significant correlation was found between DES and TAS (r=0.341), IES-R Hyperarousal (r=0.492), and IES-R Total (r=0.344) scores. The mediating function of DES in the interaction between TAS-20 and IES-R was assessed. DES is the mediator variable for the effect of TAS-20 on IES-R (β= 0.15,1 z=2.372, p=0.018). Conclusion: The study underscores the importance of dissociation as a mediating factor between alexithymia and PTSD. Addressing dissociative symptoms in therapeutic interventions may improve treatment outcomes for PTSD patients, particularly those exhibiting alexithymic traits. Future research should explore longitudinal relationships and broader samples to validate these findings. Keywords: Alexithymia, Dissociation, Mediation, Post-Traumatic Stress Disorder, Trauma.
- 31 January 2025
- Published by Turkish Journal of Traumatic Stress in Turkish Journal of Traumatic Stress
- Vol. 1 (1) , 3-13
Open AccessThe Mediating Role of Dissociation in the Relationship Between Alexithymia and Symptom Severity in Patients with Post-traumatic Stress Disorder
Background: This study aimed to reveal the complex relationship between symptom severity, dissociation, and alexithymia in patients with post-traumatic stress disorder (PTSD). It also focuses on whether dissociative symptoms mediate the link between alexithymia and PTSD symptom severity. Methods: The study included 85 patients who were referred to a psychiatric clinic and diagnosed with PTSD according to the Diagnostic and Statistical Manual of Mental Disorders-5 diagnostic criteria. Participants were assessed using the sociodemographic data form, the Event Impact Scale-Revised (IES-R), the Dissociative Experiences Scale (DES), and the Toronto Alexithymia Scale (TAS-20). Results: The mean age of 85 PTSD patients included in the study was 31.90 years and 69.4% (n=59) were female. According to the TAS-20 scale of the participants; 62.4% (n=53) were alexithymic and 37.6% (n=32) were non-alexithymic. The two groups had no statistically significant difference in sociodemographic variables (p>0.05). A statistically significant difference was found between the two groups in DES (p=0.004) and TAS (p<0.001). A positive statistically significant correlation was found between DES and TAS (r=0.341), IES-R Hyperarousal (r=0.492), and IES-R Total (r=0.344) scores. The mediating function of DES in the interaction between TAS-20 and IES-R was assessed. DES is the mediator variable for the effect of TAS-20 on IES-R (β= 0.15,1 z=2.372, p=0.018). Conclusion: The study underscores the importance of dissociation as a mediating factor between alexithymia and PTSD. Addressing dissociative symptoms in therapeutic interventions may improve treatment outcomes for PTSD patients, particularly those exhibiting alexithymic traits. Future research should explore longitudinal relationships and broader samples to validate these findings. Keywords: Alexithymia, Dissociation, Mediation, Post-Traumatic Stress Disorder, Trauma.
- Open Access
- 3 December 2024
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 12 (6) , qfae085
Comparison of melanocortin-4 reptor and α-melanoside stimulated hormone levels in healthy female volunteers and female patients with and without sexual functional disorders related to the use of selective serotonin reaptake inhibitors
Background: Sexual dysfunction (SD) due to Selective Serotonin Reuptake Inhibitors (SSRI) use is a common condition encountered by psychiatrists and its etiology has not been fully elucidated. Aim: To determine the relationship between alpha Melanocyte Stimulating Hormone (α-MSH) and Melanocortin-4 receptor (MCR4) levels and sexual function levels of patients with and without SSRI related SD and control group and to examine whether α-MSH and MCR4 play a role in the etiology of SSRI related SD. Methods: A total of 92 patients and 49 healthy volunteers who applied to psychiatry outpatient clinic were included in the study. Sociodemographic form, sexual history form, Structured Clinical Interview for DSM 5, Psychotropic Related Sexual Dysfunction-Turkish version (PreSexDQ-T), Arizona Sexual Experiences Scale, Beck Depression and Anxiety Inventory were used in the evaluation interview with the referred patients. Patient groups were formed according to whether there was SSRI related SD according to the sexual history and PreSexDQ-T scale. Outcomes: The α-MSH and MCR4 levels were significantly lower in patients with SD due to SSRI use. Results: α-MSH and MCR4 levels were lower in the SSRI related SD (SSRI-SD (+)) group than in the not experiencing SD with SSRIs (SSRI-SD (–)) and control groups. The mean α-MSH and MCR4 value of the control group was found to be significantly higher than the SSRI-SD (+) patient group, the mean MCR4 value of the control group was found to be significantly higher than the mean MCR4 value of the SSRI-SD (–) patient group. The mean MCR4 and a-MSH values of the SSRI-SD(+) group using SSRI with fluoxetine were significantly lower than the SSRI-SD (–) group using SSRI with fluoxetine. Clinical implications: There is a role for α-MSH and MCR4 in SSRI related SD. Strengths and limitations: Its strength is that it is the first human study in this field. Limitations include small sample size and unknown baseline levels of α-MSH and MCR4. Conclusion: The fact that α-MSH and MCR4 play a role in the etiology of SD due to SSRI use in woman and that there was a significant difference between SSRI-SD (+) and SSRI-SD (–) groups when α-MSH and MCR4 levels were compared in fluoxetine users supports the hypothesis that serotonin may mediate SD via α-MSH and MCR4 through 5-hydroxytryptamine-2C (5-HT2C) antagonism.
- 3 December 2024
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 12 (6) , qfae085
Open AccessComparison of melanocortin-4 reptor and α-melanoside stimulated hormone levels in healthy female volunteers and female patients with and without sexual functional disorders related to the use of selective serotonin reaptake inhibitors
Background: Sexual dysfunction (SD) due to Selective Serotonin Reuptake Inhibitors (SSRI) use is a common condition encountered by psychiatrists and its etiology has not been fully elucidated. Aim: To determine the relationship between alpha Melanocyte Stimulating Hormone (α-MSH) and Melanocortin-4 receptor (MCR4) levels and sexual function levels of patients with and without SSRI related SD and control group and to examine whether α-MSH and MCR4 play a role in the etiology of SSRI related SD. Methods: A total of 92 patients and 49 healthy volunteers who applied to psychiatry outpatient clinic were included in the study. Sociodemographic form, sexual history form, Structured Clinical Interview for DSM 5, Psychotropic Related Sexual Dysfunction-Turkish version (PreSexDQ-T), Arizona Sexual Experiences Scale, Beck Depression and Anxiety Inventory were used in the evaluation interview with the referred patients. Patient groups were formed according to whether there was SSRI related SD according to the sexual history and PreSexDQ-T scale. Outcomes: The α-MSH and MCR4 levels were significantly lower in patients with SD due to SSRI use. Results: α-MSH and MCR4 levels were lower in the SSRI related SD (SSRI-SD (+)) group than in the not experiencing SD with SSRIs (SSRI-SD (–)) and control groups. The mean α-MSH and MCR4 value of the control group was found to be significantly higher than the SSRI-SD (+) patient group, the mean MCR4 value of the control group was found to be significantly higher than the mean MCR4 value of the SSRI-SD (–) patient group. The mean MCR4 and a-MSH values of the SSRI-SD(+) group using SSRI with fluoxetine were significantly lower than the SSRI-SD (–) group using SSRI with fluoxetine. Clinical implications: There is a role for α-MSH and MCR4 in SSRI related SD. Strengths and limitations: Its strength is that it is the first human study in this field. Limitations include small sample size and unknown baseline levels of α-MSH and MCR4. Conclusion: The fact that α-MSH and MCR4 play a role in the etiology of SD due to SSRI use in woman and that there was a significant difference between SSRI-SD (+) and SSRI-SD (–) groups when α-MSH and MCR4 levels were compared in fluoxetine users supports the hypothesis that serotonin may mediate SD via α-MSH and MCR4 through 5-hydroxytryptamine-2C (5-HT2C) antagonism.
- 6 September 2024
- Published by Springer Nature in Current Psychology
- Vol. 43 (38) , 30221-30229
The effectiveness of cognitive behavioral group psychotherapy for obsessive-compulsive disorder: randomized controlled study for cultural adaptation
- 6 September 2024
- Published by Springer Nature in Current Psychology
- Vol. 43 (38) , 30221-30229
The effectiveness of cognitive behavioral group psychotherapy for obsessive-compulsive disorder: randomized controlled study for cultural adaptation
- Open Access
- 1 January 2024
- Published by Kare Publishing in Dusunen Adam: Journal of Psychiatry and Neurological Sciences
- Vol. 37 (3) , 155-163
The relationship of childhood trauma, anxiety, and sexual satisfaction in Turkish men with erectile dysfunction
Objective: Childhood traumas (CT), particularly sexual abuse, are linked with sexual dysfunction and reduced sexual satisfaction. This study explores the association between CT, anxiety, and sexual satisfaction in individuals with erectile dysfunction (ED). Method: The study cohort consisted of 93 patients with ED and 95 control group volunteers. Participants completed self-report forms on demographic data and sexual histories, along with the Childhood Trauma Questionnaire (CTQ), the State and Trait Anxiety Inventory (STAI), and the Golombok-Rust Inventory of Sexual Satisfaction (GRISS). Results: Forty participants from the ED groups also had a co-diagnosis of premature ejaculation (PE). Those with co-morbid PE were categorized as a separate group (ED + PE). Physical abuse, sexual abuse, and minimization as measured by the CTQ, along with impotence, infrequency, and dissatisfaction as measured by the GRISS, were significantly lower in the control group compared to the ED and ED + PE groups (p<0.001). Anxiety scores were significantly different between the ED + PE group and both the ED and control groups (p<0.001). A history of childhood sexual abuse was linked to avoidance behavior (p<0.05). Significant correlations were observed between emotional maltreatment and PE (p<0.05), impotence and minimization (p<0.001), impotence and psychical neglect (p<0.05), and tactile avoidance and emotional neglect (p<0.01). Conclusion: This study highlights the importance of CT, including types other than sexual abuse, in contributing to sexual dysfunction and diminished satisfaction.
- 1 January 2024
- Published by Kare Publishing in Dusunen Adam: Journal of Psychiatry and Neurological Sciences
- Vol. 37 (3) , 155-163
Open AccessThe relationship of childhood trauma, anxiety, and sexual satisfaction in Turkish men with erectile dysfunction
Objective: Childhood traumas (CT), particularly sexual abuse, are linked with sexual dysfunction and reduced sexual satisfaction. This study explores the association between CT, anxiety, and sexual satisfaction in individuals with erectile dysfunction (ED). Method: The study cohort consisted of 93 patients with ED and 95 control group volunteers. Participants completed self-report forms on demographic data and sexual histories, along with the Childhood Trauma Questionnaire (CTQ), the State and Trait Anxiety Inventory (STAI), and the Golombok-Rust Inventory of Sexual Satisfaction (GRISS). Results: Forty participants from the ED groups also had a co-diagnosis of premature ejaculation (PE). Those with co-morbid PE were categorized as a separate group (ED + PE). Physical abuse, sexual abuse, and minimization as measured by the CTQ, along with impotence, infrequency, and dissatisfaction as measured by the GRISS, were significantly lower in the control group compared to the ED and ED + PE groups (p<0.001). Anxiety scores were significantly different between the ED + PE group and both the ED and control groups (p<0.001). A history of childhood sexual abuse was linked to avoidance behavior (p<0.05). Significant correlations were observed between emotional maltreatment and PE (p<0.05), impotence and minimization (p<0.001), impotence and psychical neglect (p<0.05), and tactile avoidance and emotional neglect (p<0.01). Conclusion: This study highlights the importance of CT, including types other than sexual abuse, in contributing to sexual dysfunction and diminished satisfaction.
- 1 January 2023
- Published by Turkish Association of Nervous and Mental Health in Turkish Journal of Psychiatry
- Vol. 36, 13-114
Turkish Version of the Psychotropic Related Sexual Dysfunction Questionnaire (PRSEXDQ-T): Validity and Reliability in Patients Using Selective Serotonin Reuptake Inhibitor
Sexual dysfunctions (SD) are very common in patients with psychiatric disorders and may be due to the side effects of the disease or medications used. Current scales cannot distinguish whether SDs are due to psychiatric illness or medications use. The Psychotropic Associated Sexual Dysfunction Questionnaire (PRSexDQ) is a customized scale for screening SD due to drug use. Our aim is to conduct a validity and reliability study of PRSexDQ in patients using selective serotonin reuptake inhibitors (SSRIs). One hundred patients who applied to psychiatry outpatient clinic and received SSRI treatment for at least 1 month were included in the study. These patients were evaluated by a psychiatrist, and completed the PRSexDQ-T, Arizona Sexual Experience Scale (ASEX), Golombok Rust Inventory Sexual Satisfaction (GRISS). The Cronbach's Alpha coefficient was calculated as 0.906 for the analysis performed to evaluate the internal consistency of the PRSexDQ-T. In the item-total score analysis, the correlation of all items with the total score was found to be quite high (above 0.7). Correlation coefficients were found between 0.939 and 0.985, which was used to determine the test-retest correlation for each item, and all values were statistically significant (p<0.01). In the Pearson correlation analysis performed for validity analysis, a large positive correlation was found between PRSexDQ-T and ASEX and GRISS male-female total and subscale scores. The Turkish version of PRSexDQ is a valid and reliable measurement tool in the sample of patients using SSRIs to evaluate the level of sexual dysfunction.
- 1 January 2023
- Published by Turkish Association of Nervous and Mental Health in Turkish Journal of Psychiatry
- Vol. 36, 13-114
Turkish Version of the Psychotropic Related Sexual Dysfunction Questionnaire (PRSEXDQ-T): Validity and Reliability in Patients Using Selective Serotonin Reuptake Inhibitor
Sexual dysfunctions (SD) are very common in patients with psychiatric disorders and may be due to the side effects of the disease or medications used. Current scales cannot distinguish whether SDs are due to psychiatric illness or medications use. The Psychotropic Associated Sexual Dysfunction Questionnaire (PRSexDQ) is a customized scale for screening SD due to drug use. Our aim is to conduct a validity and reliability study of PRSexDQ in patients using selective serotonin reuptake inhibitors (SSRIs). One hundred patients who applied to psychiatry outpatient clinic and received SSRI treatment for at least 1 month were included in the study. These patients were evaluated by a psychiatrist, and completed the PRSexDQ-T, Arizona Sexual Experience Scale (ASEX), Golombok Rust Inventory Sexual Satisfaction (GRISS). The Cronbach's Alpha coefficient was calculated as 0.906 for the analysis performed to evaluate the internal consistency of the PRSexDQ-T. In the item-total score analysis, the correlation of all items with the total score was found to be quite high (above 0.7). Correlation coefficients were found between 0.939 and 0.985, which was used to determine the test-retest correlation for each item, and all values were statistically significant (p<0.01). In the Pearson correlation analysis performed for validity analysis, a large positive correlation was found between PRSexDQ-T and ASEX and GRISS male-female total and subscale scores. The Turkish version of PRSexDQ is a valid and reliable measurement tool in the sample of patients using SSRIs to evaluate the level of sexual dysfunction.
- 19 November 2022
- Published by Springer Nature in Current Psychology
- Vol. 42 (33) , 29481-29498
How much are they predictive for obsessive-compulsive symptom dimensions: beliefs, emotions, emotional schemas?
- 19 November 2022
- Published by Springer Nature in Current Psychology
- Vol. 42 (33) , 29481-29498
How much are they predictive for obsessive-compulsive symptom dimensions: beliefs, emotions, emotional schemas?
- Open Access
- 7 April 2022
- Published by AVES YAYINCILIK A.Ş. in Psychiatry and Clinical Psychopharmacology
- Vol. 32 (1) , 45-53
Turkish Version of the Psychosis Attachment Measure: A Reliability and Validity Analysis
Schizophrenia,psychotic disorders,attachment,depression
- 7 April 2022
- Published by AVES YAYINCILIK A.Ş. in Psychiatry and Clinical Psychopharmacology
- Vol. 32 (1) , 45-53
Open AccessTurkish Version of the Psychosis Attachment Measure: A Reliability and Validity Analysis
Schizophrenia,psychotic disorders,attachment,depression
- 13 January 2022
- Published by Springer Nature in Current Psychology
- Vol. 42 (16) , 13288-13300
The relationship between symptom dimensions and cognitive features in obsessive compulsive disorder
- 13 January 2022
- Published by Springer Nature in Current Psychology
- Vol. 42 (16) , 13288-13300
The relationship between symptom dimensions and cognitive features in obsessive compulsive disorder